| Current Price | $140.48 | Mkt Cap | $22.4B |
|---|---|---|---|
| Open | $140.51 | P/E Ratio | 0.00 |
| Prev. Close | $140.48 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $139.75 - $143.24 | Volume | 1,702 |
| 52-Wk Range | $120.67 - $308.00 | Avg. Daily Vol. | 2,112,091 |
| Current Price | $140.48 | Mkt Cap | $22.4B |
|---|---|---|---|
| Open | $140.51 | P/E Ratio | 0.00 |
| Prev. Close | $140.48 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $139.75 - $143.24 | Volume | 1,702 |
| 52-Wk Range | $120.67 - $308.00 | Avg. Daily Vol. | 2,112,091 |
The best Bull and Bear pitches based on recency and number of recommendations.
As more people get used to video conferences with doctors due to Covid restrictions, and some trying audio and realizing that it does not let you see the doctor's expressions, I believe TDOC will continue to grow.
I don’t see much of a moat for this business. In my area, there are many virtual physician services. I don’t see why this one will be a winner as this seems likely to roll to the lowest cost provider, which will probably provide PAs from India (… More
Read the most recent pitches from players about TDOC.
Recs
TMFJaguar
(85.31)
Submitted: 10/19/2021 2:28:44 PM :
Start Price:
$139.04
NYSE:TDOC Score:
+0.48
Subscription revenue is still growing and that drives profit margin expansion. Cross sell opportunities with Livongo health are still forthcoming, to say nothing of Teladoc's and Livongo's own organic growth that's continuing. Management says 30% to 40% annual revenue growth through 2023. With expanding margins, positive cash flow, revenue growth, and a stock that's now cheaper than it was before the pandemic, I think it has a chance of beating the market from here.
Recs
Brainsliver
(79.85)
Submitted: 9/30/2021 12:35:36 PM :
Start Price:
$126.08
NYSE:TDOC Score:
+6.35
Leader in telemedicine with name recognition and stability (which is key criteria for hospitals looking at their service.)
Recs
LavPatel
(55.89)
Submitted: 8/26/2021 12:33:29 PM :
Start Price:
$141.57
NYSE:TDOC Score:
-1.78
1. Undervalued considering its position as a leader in telehealth.
2. Livongo acquisition should add a lot of value in the long run.
3. Telehealth services likely to continue to grow and replace simpler health checkups and prescription calls.
Find the members with the highest scoring picks in TDOC.
andrewhoyt1996 (< 20) Score: +1,124.47
The Score Leader is the player with the highest score across all their picks in TDOC.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| andrewhoyt1996 | < 20 | 4/13/2016 |
|
1Y | $10.46 | +1,243.02% | +118.56% | +1,124.47 | 2 Comments | |
| bikeshopowner | 68.44 | 5/26/2016 |
|
5Y | $10.90 | +1,188.81% | +116.01% | +1,072.80 | 0 Comment | |
| arsenaltx | < 20 | 4/18/2016 |
|
5Y | $11.14 | +1,161.04% | +118.41% | +1,042.63 | 0 Comment | |
|
KenCam21 | 61.16 | 4/15/2016 |
|
5Y | $11.22 | +1,152.05% | +117.49% | +1,034.56 | 1 Comment |
| wmtworker | 80.67 | 6/10/2016 |
|
5Y | $12.83 | +994.79% | +114.68% | +880.11 | 0 Comment | |
| PinkFloydFan | 34.09 | 6/29/2016 |
|
5Y | $14.58 | +863.51% | +120.86% | +742.65 | 0 Comment | |
| nibblebitbyte | 56.14 | 7/8/2016 |
|
5Y | $15.06 | +832.80% | +114.36% | +718.44 | 0 Comment | |
| wadethefred | 69.78 | 7/8/2016 |
|
5Y | $15.06 | +832.80% | +114.36% | +718.44 | 1 Comment | |
|
|
camistocks | 75.00 | 7/15/2016 |
|
5Y | $15.51 | +805.74% | +108.70% | +697.04 | 0 Comment |
|
|
statism1 | 90.39 | 7/18/2016 |
|
5Y | $15.50 | +806.32% | +109.48% | +696.84 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
